Studies
-
Status: Completion
Treatment Outcomes of Multi-drug resistant TB (MDR-TB) treatment: shorter MDR TB treatment regimen compared with standard of care in Uzbekistan
-
Status: Completion
Association between bedaquiline use and QT interval: a cohort analysis of data from a drug-resistant tuberculosis programme in Chechnya and Uzbekistan
-
Status: Completion
Household tuberculosis contact-tracing in Tajikistan: active case finding in a high MDR-TB setting
-
Status: Completion
Detection of Mycobacterium tuberculosis complex using Xpert MTB/RIF Ultra in the stool of paediatric patients
-
Status: Completion
A retrospective cohort analysis of bedaquiline resistance in patients with Rifampicin Resistant TB with or without second line drug resistance, Karakalpakstan (2015-2020)
Principal investigator: Parvati NairLatest update: Publication added | 10th May 2023Impact: Programmes added by Animesh sinha | 30th Jun 2022
-
Status: Completion
Children and adolescents treated for rifampicin-resistant tuberculosis: an updated systematic review and individual patient data meta-analysis
Study details: Systematic reviewLatest update: Note left | 10th August 2022
-
Status: Completion
Description of MSF program cohort of drug-resistant tuberculosis (DR-TB) paediatric patients on Family DOT model of care, Tajikistan.
Principal investigator: Tajikistan mental health activity managerLatest update: Publication added | 28th July 2022
-
Status: Study was withdrawn or postponed
Post Exposure Screening and Management of household contacts of drug-resistant tuberculosis in Dushanbe, Tajikistan
Principal investigator: Elkin BermudezLatest update: Implementation update added | 26th September 2023
-
Status: Completion
A retrospective review of isoniazid mono resistant cases of tuberculosis managed in Karakalpakstan, Uzbekistan 2010-2018
-
Status: Implementation
Implementation of all oral 24 weeks regimen for DR-TB patients
Study details: Other in Afghanistan , Belarus , Congo (Democratic Republic of the) , Myanmar , Russian Federation , Sierra Leone , Somalia , South Sudan , Tajikistan , UzbekistanLatest update: 10th August 2023
-
Status: Implementation
The epidemiology of second-line anti-tuberculosis drug resistance pattern in Karakalpakstan (KK), Uzbekistan, from 2017-2022